# Probiotics Combined With Chemotherapy for Patients With Advanced NSCLC

> **NCT03642548** · PHASE3 · UNKNOWN · sponsor: **Shanghai 10th People's Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Probiotics Plus Chemotherapy

## Interventions

- **DRUG:** bifico
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03642548
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-21
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2019-02-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03642548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03642548, "Probiotics Combined With Chemotherapy for Patients With Advanced NSCLC". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03642548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*